Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Caredx Inc (NQ: CDNA )

24.70 -1.22 (-4.71%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 857,342
Open 25.74
Bid (Size) 24.25 (5)
Ask (Size) 24.70 (1)
Prev. Close 25.92
Today's Range 24.65 - 26.23
52wk Range 7.420 - 34.84
Shares Outstanding 52,627,165
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?
Cathie Wood, CEO of ARK Invest, is doubling down on biologics, seeing unprecedented potential at the intersection of artificial intelligence, genetic sequencing, and gene editing technologies. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
CareDx to Participate in Upcoming Investor Conferences
From CareDx, Inc.
Via Business Wire

Performance

YTD
+106.87%
+106.87%
1 Month
+7.86%
+7.86%
3 Month
-8.96%
-8.96%
6 Month
+60.18%
+60.18%
1 Year
+156.22%
+156.22%

More News

Read More
Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review
Via Investor's Business Daily
Topics Economy Government
Exposures Interest Rates Political
A Closer Look at 5 Analyst Recommendations For CareDx
Via Benzinga
5 Analysts Assess CareDx: What You Need To Know
Via Benzinga
What 4 Analyst Ratings Have To Say About CareDx
Via Benzinga
CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance
From CareDx, Inc.
Via Business Wire
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
Via Benzinga
Topics ETFs Stocks
Exposures US Equities
CareDx and Dovetail Genomics Announce Strategic Partnership to Drive Next Wave of Innovation in Transplant Matching with Cutting-Edge Hi-C Technology
From CareDx, Inc.
Via Business Wire
CareDx Showcases Latest Advancements Across its HLA Typing Solutions at Annual American Society for Histocompatibility and Immunogenetics Meeting
From CareDx, Inc.
Via Business Wire
Nasdaq Down 150 Points; Johnson & Johnson Reports Better-Than-Expected Q3 Results
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Crude Oil Tumbles 5%; Goldman Sachs Earnings Top Views
Via Benzinga
Exposures Fossil Fuels
CareDx, JD.com And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
CareDx Reports Preliminary Financial Results for Third Quarter 2024
From CareDx, Inc.
Via Business Wire
CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From CareDx, Inc.
Via Business Wire
CareDx Appoints Jing Huang Chief Data and AI Officer
From CareDx, Inc.
Via Business Wire
CareDx to Host Investor Day on October 15, 2024
From CareDx, Inc.
Via Business Wire
CareDx Announces Closure of DOJ Investigation with No Finding of Wrongdoing
From CareDx, Inc.
Via Business Wire
CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From CareDx, Inc.
Via Business Wire
CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From CareDx, Inc.
Via Business Wire
CareDx Appoints Keith Kennedy Chief Operating Officer and Jessica Meng Chief Commercial Officer
From CareDx, Inc.
Via Business Wire
CareDx Announces Transplant Community Secures Win Reaffirming Longstanding Medicare Coverage for AlloSure and AlloMap Testing
From CareDx, Inc.
Via Business Wire
Why Carvana Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.